Delayed Local Reactions to mRNA-1273 Vaccination Reported
Reactions appeared near injection site at a median onset of day 8 after first dose; six of 12 patients had no recurrence after second dose
Semaglutide May Aid Weight Loss in Obese Patients With T2DM
Estimated change in mean body weight to week 68 was −9.6 percent with semaglutide 2.4 mg versus −3.4 percent with placebo
Shortage of Syringes Reported for COVID-19 Shots
Billions poured into development of vaccines, but little public investment made in expanding manufacturing for syringes
Terlipressin Bests Placebo in Type 1 Hepatorenal Syndrome
Terlipressin is more effective for reversal of HRS but is associated with more adverse events and death due to respiratory disorders
California Targets Vulnerable Neighborhoods for COVID-19 Vaccination
Neighborhoods considered highly vulnerable based on factors such as income, education, housing, and transportation
COVID-19 Death Rates 10 Times Higher in Countries Where Most Are Overweight
Higher BMI also associated with increased risk for hospitalization, ICU admission, need for mechanical ventilation
Uptake of Seasonal Influenza Vaccine Lower Among Minorities
Uptake lower among Black, Asian, Hispanic adults versus Whites; those vaccinated less likely to receive high-dose vaccine
Good Response Seen With HealthCare.gov Reopening
CMS figures show more than 206,000 people signed up for coverage from Feb. 15 to 28
AAN: Antidepressants Not Tied to Increased Intracerebral Hemorrhage Risk
Selective serotonin reuptake inhibitors are not associated with higher risk for intracerebral hemorrhage

















